OpenLink Software

About: The oncology community is concerned that cancer patients will be unfairly classified in pandemic allocation guidances. Past guidances either excluded metastatic cancer patients from consideration or categorized them as having a survival of less than one year. Given recent improvements in treatments, we recommend that (1)the prognosis of an individual cancer patient be determined with input from a cancer specialist, or (2) if this is impractical, (a) The presence of active metastatic solid cancer or relapsed hematologic malignancy is graded as a major comorbidity, with a likelihood that survival will be less than 5 years; (b) Severe limitation in physical functioning (3 or 4 on the Eastern Cooperative Oncology Group performance status (ECOG‐PS) would define an advanced cancer patient as having a severe comorbidity, with a likelihood of less than 1 year survival. Cancer may be the “Emperor of all Maladies,” but it is no longer a certain death sentence.

 Permalink

an Entity references as follows:

Faceted Search & Find service v1.13.91

Alternative Linked Data Documents: Sponger | ODE     Raw Data in: CXML | CSV | RDF ( N-Triples N3/Turtle JSON XML ) | OData ( Atom JSON ) | Microdata ( JSON HTML) | JSON-LD    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] This material is Open Knowledge Creative Commons License Valid XHTML + RDFa
This work is licensed under a Creative Commons Attribution-Share Alike 3.0 Unported License.
OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Copyright © 2009-2025 OpenLink Software